CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigate Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
13,421 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0290

Tirzepatide Raw

Filed under Raw Materials. The bureau holds 54 laboratory returns for this compound from 16 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

16 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
HomopeptideCASE #VI-2026-0760A610.09.910.024 May 202624 May 2026
Tianjin Finder Chemical TFCCASE #VI-2026-0693A59.99.910.014 Nov 202516 Apr 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284A78.67.59.924 May 202624 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538A48.58.38.723 May 202623 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486A58.26.010.025 May 202625 May 2026
Verified PeptidesCASE #VI-2026-0407X17.97.97.916 Mar 202516 Mar 2025
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594A67.86.58.924 May 202624 May 2026
Planet PeptideCASE #VI-2026-0092X17.57.57.59 Jun 20259 Jun 2025
Huaian Hanyou PeptideCASE #VI-2026-0297X16.86.86.811 Jun 202511 Jun 2025
Glbiochem (Shanghai)CASE #VI-2026-0704A26.66.27.024 May 202624 May 2026
OupeptideCASE #VI-2026-0435X106.64.310.08 Jul 202526 Jan 2026
Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076X16.66.66.67 May 20257 May 2025
Mix PeptidesCASE #VI-2026-0699X16.26.26.225 Apr 202525 Apr 2025
Biolongevity LabsCASE #VI-2026-0442X35.94.96.827 Feb 202517 May 2026
Wolverine PeptidesCASE #VI-2026-0262X15.15.15.128 Mar 202528 Mar 2025
Weifang Xingbei International TradeCASE #VI-2026-0766X10.00.00.024 Apr 202524 Apr 2025

Open any subject to view the batch-level evidence for Tirzepatide Raw alone.